TBVI is an independent non-profit foundation that facilitates the development of new vaccines to protect future generations against tuberculosis.
TBVI financially supports and brings expertise to an integrated network of over 40 universities, institutes and industries to develop more effective, safe vaccines that will be globally accessible and affordable. Research conducted by mostly European based network has already resulted in promising vaccine discoveries.
New vaccines are urgently needed to stop tuberculosis. Every year around 9 million new cases of this infectious disease are recorded. Every year almost 2 million people die of TB, equaling one death every 18 seconds.
Read more about: TuBerculosis Vaccine Initiative (TBVI)
Fecha de Colaboración:
8 abril 2010